AD-MSCs were highly-expressed mesenchymal stem cell surface markers CD44, CD90 and CD105, while for the lowly-expressed haematopoietic stem cells surface markers CD34, leukocyte common antigen CD45 and major histocompatibility complex class II HLA-DR (Fig. 2B). This evidence concerns the gene THY1 and Alzheimer disease.